Zacks Investment Research
14 Aug 2026, 16:41 UTC · 14h ago
PEB or NHI: Which Is the Better Value Stock Right Now?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
14 Aug 2026, 16:41 UTC · 14h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Pebblebrook Hotel (PEB) currently holds a Zacks Rank of #1 (Strong Buy). — A top analyst rank based on positive earnings estimate revisions typically signals upward price momentum for the specific security.
+0.40National Health Investors (NHI) currently holds a Zacks Rank of #4 (Sell). — A 'Sell' rank based on negative estimate trends suggests a deteriorating fundamental outlook for the security.
-0.40Pebblebrook Hotel (PEB) has a Value grade of 'A' with a forward P/E of 10.63 and a P/B ratio of 0.82. — Strong valuation metrics indicate the stock may be undervalued, providing a margin of safety for value investors.
+0.20Continue reading
6 related stories
Search tags
National Health Investors (NHI) has a Value grade of 'D' with a forward P/E of 14.64 and a P/B ratio of 2.19. — Poor valuation grades suggest the stock is overpriced relative to its fundamentals, increasing downside risk.
Which stocks this story touches
The company has a Zacks Rank of #1 (Strong Buy) and a Value grade of A.
The company has a Zacks Rank of #4 (Sell) and a Value grade of D.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
16h ago
